PETS Stock Summary and Trading Ideas (Petmed Express | NASDAQ:PETS)

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Petmed Express trades on the NASDAQ stock market under the symbol PETS.

As of January 31, 2025, PETS stock price declined to $4.93 with 13,927 million shares trading.

PETS has a beta of 1.85, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.16 to the broad based SPY ETF.

PETS has a market cap of $101.87 million. This is considered a Micro Cap stock.

Last quarter Petmed Express reported $60 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-6 million and exceeded earnings estimates by $.16.

In the last 3 years, PETS traded as high as $29.53 and as low as $2.90.

The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, PRFZ, FNDA, ITOT.

PETS has underperformed the market in the last year with a price return of -23.4% while the SPY ETF gained +25.5%. However, in the short term, PETS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +22.3% vs +5.4% return in SPY. But in the last 2 weeks, PETS shares have been beat by the market, returning -3.3% compared to an SPY return of +3.0%.

PETS support price is $4.85 and resistance is $5.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.